Drug interactions
Cannabidiol + Glimepiride-pioglitazone
Severity: Minor
Cannabidiol and Glimepiride-pioglitazone: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Cannabidiol may inhibit CYP2C8, the main enzyme that metabolizes pioglitazone, which could raise pioglitazone exposure. This could increase dose-related effects such as fluid retention, edema and hypoglycemia.
What this interaction means in plain words
Cannabidiol and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Cannabidiol belongs to Central Nervous System; Glimepiride-pioglitazone belongs to Endocrine.
Why it happens
Possible CYP2C8 inhibition by cannabidiol reduces pioglitazone metabolism.
What to do
Monitor glucose control and signs of fluid retention or edema after cannabidiol is started or stopped. Reduce the pioglitazone dose if adverse effects appear.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cannabidiol and Glimepiride-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Glimepiride-pioglitazone
Other interactions of Cannabidiol
- Cannabidiol + Phenytoin Major
- Cannabidiol + Tacrolimus Major
- Cannabidiol + Valproic acid Major
- Abiraterone + Cannabidiol Moderate
- Alogliptin-pioglitazone + Cannabidiol Moderate
- Amiodarone + Cannabidiol Moderate
Frequently asked questions
Can I take Cannabidiol with Glimepiride-pioglitazone?
MediHelp rates the interaction as minor. Cannabidiol and Glimepiride-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cannabidiol may inhibit CYP2C8, the main enzyme that metabolizes pioglitazone, which could raise pioglitazone exposure. This could increase dose-related effects such as fluid retention, edema and hypoglycemia.
How serious is the interaction between Cannabidiol and Glimepiride-pioglitazone?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose control and signs of fluid retention or edema after cannabidiol is started or stopped. Reduce the pioglitazone dose if adverse effects appear.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
